Sign in

Terrence W. Glarner

Chairman of the Board at NVE CORP /NEW/
Board

About Terrence W. Glarner

Independent Chairman of the Board of NVE; director since 1999 (tenure 26 years) and Chairman since January 2001; age 82 as of June 13, 2025. Education: B.A. in English (University of St. Thomas), J.D. (University of Minnesota School of Law), and Chartered Financial Analyst (CFA). Career: President of West Concord Ventures, Inc. since 1993; prior service as a director of several publicly traded companies; retired director of privately-held Bremer Financial Corp. in 2018 .

Past Roles

OrganizationRoleTenure/DatesCommittees/Impact
NVE CorporationIndependent Director; Chairman of the BoardDirector since 1999; Chairman since Jan 2001Board leadership; liaison between CEO and independent directors; presides over executive sessions; risk oversight
NVE CorporationAudit Committee memberOngoingAudit Committee member; Board determined “audit committee financial expert”; cybersecurity oversight
NVE CorporationCompensation Committee ChairOngoingOversees human capital; sets exec comp guidelines; administers option plan
NVE CorporationNominating/Corporate Governance Committee ChairOngoingBoard refreshment, committee selection, governance matters
West Concord Ventures, Inc.PresidentSince 1993Venture capital leadership experience
Bremer Financial Corp. (private)DirectorUntil 2018Board service at private financial institution
Various publicly traded companies (unspecified)Director (past)Not disclosedGeneral public company board experience

External Roles

OrganizationRoleTenure/DatesNotes
West Concord Ventures, Inc.PresidentSince 1993Venture capital company
Bremer Financial Corp. (private)DirectorUntil 2018Retired from role in 2018
Various publicly traded companies (unspecified)Director (past)Not disclosedCompanies not named in proxy

Board Governance

  • Independence: Board determined all directors except the CEO are independent under SEC Rule 10A-3 and Nasdaq Rule 5605(a)(2); Glarner is independent .
  • Board leadership: NVE separates Chair and CEO since 2001; Glarner serves as independent Chairman with oversight, agenda-setting, and shareholder liaison responsibilities .
  • Committees: Audit (member), Compensation (Chair), Nominating/Corporate Governance (Chair); all committees comprised solely of independent directors .
  • Attendance and engagement: Board met five times in fiscal 2025; each current director attended at least 75% of Board and committee meetings; independent directors meet in executive session at every regular meeting .
  • Overboarding policy: Non-NEO directors limited to three other public boards; all directors comply .
  • Board evaluation: Annual independent-managed self-evaluations; informs skills matrix and composition decisions .

Fixed Compensation

ComponentFY 2024FY 2025
Quarterly cash retainer ($2,500/quarter)$10,000 $10,000
Chairman fee ($250/quarter)$1,000 $1,000
Audit Chair fee ($125/quarter)$0 (not Audit Chair) $0 (not Audit Chair)
Fees Earned or Paid in Cash (total)$11,000 $11,000
PerquisitesNone provided None provided

Notes: Non-employee directors automatically receive immediately vested nonqualified options to purchase 1,000 shares upon each re-election; no director meeting fees disclosed; unpaid cash compensation forfeited on termination/retirement/disability/death .

Performance Compensation

MetricFY 2024FY 2025
Option Awards (grant-date fair value)$23,442 $22,735
Director annual option grant policy1,000 options at each re-election, immediately vested 1,000 options at each re-election, immediately vested
Options outstanding and exercisable (as of fiscal year-end)6,000 6,000

Notes: Grant-date fair values determined via Black-Scholes-Merton assumptions per 10-K Note 5; director grants are immediately vested, not performance-contingent .

Other Directorships & Interlocks

  • Current public company boards: None disclosed for Glarner beyond NVE .
  • Prior boards: “Several other publicly traded companies” (not named); Bremer Financial Corp. (private), retired 2018 .
  • Interlocks: No related-party or interlocking directorships with NVE customers/suppliers disclosed; audit committee reviews related party transactions; Company reports no related-person transactions in the past two fiscal years .

Say-on-Pay & Shareholder Feedback

Item2024 Annual Meeting (Aug 1, 2024)2025 Annual Meeting (Aug 7, 2025)
Directors elected – Glarner votes For/Withheld2,782,656 For; 340,003 Withheld 2,986,541 For; 283,523 Withheld
Say-on-Pay votes (For/Against/Abstain)3,015,808 For; 89,586 Against; 17,267 Abstain 3,171,573 For; 87,852 Against; 10,637 Abstain
Proxy-reported say-on-pay approval rate97% approval at 2024 Annual Meeting Not stated in proxy; item approved per 8-K

Expertise & Qualifications

  • Skills matrix: Public company directorship experience; electronics/semiconductor industry experience; medical device industry exposure; corporate development/M&A; financial expert; cybersecurity; climate risk; human capital; health and safety; compensation alignment; succession planning; independent of management .
  • Education and credentials: BA (English), JD (Law), CFA; qualifies to serve as Chairman; Audit Committee members (including Glarner) designated “audit committee financial experts” under Item 407 .

Equity Ownership

MetricValue
Beneficial ownership (shares) as of June 13, 20256,540 (includes options described below)
Options included in beneficial ownership6,000 shares currently exercisable
Ownership % of shares outstandingLess than 1% (asterisk in table)
Shares outstanding reference4,837,166 shares outstanding as of June 13, 2025
Pledging/HedgingCompany prohibits directors/officers from pledging, hedging, short sales, and derivatives on company stock
Rule 10b5-1 Plans (Q4 FY2025)None adopted or terminated; no plans in effect

Compensation Committee Analysis

  • Composition and independence: Compensation Committee consists of Glarner (Chair), Hollister, and Wei; all are independent under Nasdaq Rule 5605(d)(2)(A); committee charter prohibits members from accepting consulting/advisory/compensatory fees from the Company (board fees excluded) .
  • Use of consultants and benchmarking: Committee has authority to retain advisors but has not employed compensation consultants; no peer-based benchmarking; relies on surveys and government data (e.g., U.S. Bureau of Labor Statistics/Federal Reserve) .
  • Equity award timing: Director option grants are automatic on Annual Meeting date; Committee states it does not time awards around material nonpublic information; NEO option grant policy adjusted to occur two business days after fiscal results release beginning FY2025 .

Related Party Transactions and Conflicts

  • Company disclosure: No related-party transactions involving directors or related persons in the last two fiscal years; audit committee has formal preapproval and conflict review process under Nasdaq Rule 5630(a) and Minnesota statutes .
  • Golden leashes: Directors disclosed no arrangements for compensation by third parties (“golden leashes”) .

Risk Indicators & Red Flags

  • Section 16 compliance: All reports filed timely for FY2024; no delinquent filers noted .
  • Legal proceedings: No material pending or threatened proceedings disclosed .
  • Hedging/pledging: Prohibited for directors/officers, reducing alignment risk concerns .
  • Board refreshment: No age or term limits; Board relies on evaluations and compensation policies to encourage refreshment—considering Glarner’s long tenure and age, this governance approach merits monitoring for succession and refreshment balance .
  • Director equity awards: Immediate vesting options (non-performance-based), typical for directors but not tied to specific performance metrics .

Governance Assessment

  • Strengths: Independent Chairman with deep public company and semiconductor sector experience; dual committee chair roles (Compensation; Nominating/Governance) support governance effectiveness; robust committee independence and clear charters; strong say-on-pay support (97% in 2024) signaling shareholder confidence; modest director cash fees; formal prohibitions on hedging/pledging; no related-party transactions .
  • Watch items: Advanced age and extended tenure alongside the absence of formal age/term limits; director equity awards are immediately vested options with no performance conditions (standard for directors, but monitor alignment via ownership levels); continued oversight of succession and refreshment practices advisable .